Avacta Group Plc (AIM:AVCT)
55.75
+0.25 (0.45%)
Jan 22, 2026, 4:20 PM GMT
Avacta Group Employees
Avacta Group had 151 employees as of December 31, 2024. The number of employees decreased by 3 or -1.95% compared to the previous year.
Employees
151
Change (1Y)
-3
Growth (1Y)
-1.95%
Revenue / Employee
748.34 GBP
Profits / Employee
-414.60K GBP
Market Cap
242.76M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 151 | -3 | -1.95% |
| Dec 31, 2023 | 154 | 34 | 28.33% |
| Dec 31, 2022 | 120 | -13 | -9.77% |
| Dec 31, 2021 | 133 | 10 | 8.13% |
| Dec 31, 2020 | 123 | 4 | 3.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Oxford Nanopore Technologies | 1,382 |
| Oxford Biomedica | 850 |
| hVIVO | 301 |
| 4basebio | 110 |
| Scancell Holdings | 60 |
| PureTech Health | 56 |
| SkinBioTherapeutics | 41 |
| Faron Pharmaceuticals Oy | 25 |
Avacta Group News
- 5 weeks ago - Avacta Group Plc (AVCTF) Discusses Initial Faridoxorubicin Phase Ib Data and Safety Profile in Salivary Gland Cancer Transcript - Seeking Alpha
- 2 months ago - Full Year 2024 Avacta Group PLC Live Presentation Transcript - GuruFocus
- 3 months ago - Avacta (AIM) Reports Promising Results in Faridoxorubicin Clinical Trial - GuruFocus
- 3 months ago - Half Year 2025 Avacta Group PLC Live Presentation Transcript - GuruFocus
- 4 months ago - Avacta Group Plc (AVCTF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Avacta Group Plc 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 4 months ago - Avacta Group (AVCTF) Reports Flat Revenue in First-Half Earnings - GuruFocus
- 4 months ago - Avacta Group Plc GAAP EPS of 4.46p, revenue of £0.06M - Seeking Alpha